119. A Humanized Antibody Targeting the CotH Invasins is Protective Against Murine Mucormycosis

BACKGROUND: Despite antifungal therapy and surgical debridement, overall mortality of invasive mucormycosis is >40%. Currently the world is witnessing an explosion in mucormycosis in India among COVID-19 patients with an official count of 28,252 cases as of 06/07/2021. Thus, novel therapeutic mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Yiyou, Alqarihi, Abdullah, Singh, Shakti, Gebremariam, Teclegiorgis, Alkhazraji, Sondus, Youssef, Eman, Andes, David, Ibrahim, Ashraf S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Oral Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644226/
http://dx.doi.org/10.1093/ofid/ofab466.119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644226/
http://dx.doi.org/10.1093/ofid/ofab466.119

Ejemplares similares